PMA device
Integra(R) Dermal Regeneration Template
Integra Lifesciences Corp. · Device, Dermal Replacement (MDD, Class III) · First FDA decision Apr 19, 2002, newest May 9, 2016BurnsChronic wounds and ulcers
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
32
Naming "Integra"
MAUDE reports
1,885
Brand "Integra", since 2015
PubMed studies
1,232
Mentioning "Integra"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Integra(R) Dermal Regeneration Template
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- INTEGRA(R) DERMAL REGENERATION TEMPLATE, INTEGRA(R) MESHED DERMAL REGENERATION TEMPLATEPMA supplement
P900033-S053 · Decided May 9, 2016 · 188 days after receipt · Normal 180 Day Track
Device type: Device, dermal replacement (MDD) · General & Plastic Surgery
P900033-S054 · Decided May 3, 2016 · 161 days after receipt · Normal 180 Day Track No User Fee
Device type: Device, dermal replacement (MDD) · General & Plastic Surgery
- INTEGRA(R) DERMAL REGENERATION TEMPLATE,INTEGRA(R) MESHED DERMAL REGENERATION TEMPLATE,OMNIGRAFT (TM) DERMAL REGENERATIOPMA supplement
P900033-S042 · Decided Jan 7, 2016 · 343 days after receipt · Panel Track
Device type: Device, dermal replacement (MDD) · General & Plastic Surgery
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Cardiointegram (CIG) as an Alternative to Stress Test or Thallium Stress TestNational determinationOn the books20.27Updated Apr 17, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "Integra", any status and sponsor, newest update first.
- Assessment of Combined CCM and ICD Device in HFrEFActive, not recruiting
Impulse DynamicsNot on our public-company list
NCT05855135 · 300 participants (planned) · Start May 17, 2023 · Primary completion Dec 31, 2025
Device: OPTIMIZER® Integra CCM-D System (Treatment Arm) · For: Heart Failure; Heart Failure With Reduced Ejection Fraction; Implantable Defibrillator User and 7 more
Sites: Glendale, Arizona; Mesa, Arizona; Phoenix, Arizona · 59 sites in all
University of North Carolina, Chapel HillAcademic, hospital or other
NCT06331052 · 24 participants (planned) · Start Feb 28, 2024 · Primary completion Feb 28, 2028
Device: MR-guided Focused Ultrasound Ablation · For: Essential Tremor
Sites: Chapel Hill, North Carolina
- Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint ReplacementTerminated
Smith & Nephew, Inc.Public (SNN)
NCT03247023 · 65 participants · Start Sep 18, 2017 · Primary completion Sep 6, 2023
Device: Implantation of Integra Cadence Total Ankle System · For: Degenerative Arthritis; Rheumatoid Arthritis; Traumatic Arthritis
Sites: Ghent, Belgium; Woluwe-St-Lambert, Belgium; Toronto, Canada · 6 sites in all
29 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Integra", and for the whole product code for context.
This brand
1,885 reports: 1,586 malfunction, 293 injury, 3 death
Whole product code MDD
144 reports: 49 malfunction, 91 injury, 4 death
Newest reports for this brand
- Integra® Jarit®Malfunction
INTEGRA LIFESCIENCES PRODUCTION CORPORATION
51135028 · Received Oct 19, 2026 · Event dated Sep 23, 2026
Device type: Hemostat (HRQ)
Device problem as coded: Break
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- BD INTEGRA PrecisionGlideMalfunction
BECTON DICKINSON MEDICAL SYSTEMS
1213809-2026-00538 · Received Oct 19, 2026 · Event dated Sep 25, 2026
Device type: Syringe, Antistick (MEG)
Device problem as coded: Detachment of Device or Device Component
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- cobas Integra 400 plusMalfunction
1823260-2026-04123 · Received Oct 6, 2026 · Event dated Sep 11, 2026
Device type: Analyzer, Chemistry (Photometric, Discrete), For Clinical Use (JJE)
Device problem as coded: Infusion or Flow Problem; Insufficient Device Problem Information
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1035-2009 · Started Jan 16, 2009 · Posted by FDA Mar 6, 2009
Reason given: Potential for open seals in the inner foil pouch of certain products. The outer seal remains intact and therefore the sterility of the inner pouch is maintained.
Cause as FDA categorized it: Pending · Device type: Device, Dermal Replacement (MDD)
Z-2328-2008 · Started Jul 2, 2008 · Posted by FDA Sep 20, 2008
Reason given: Product labeled with an expiration date on May 2010, while the actual expiration date should be April 2010.
Cause as FDA categorized it: Labeling mix-ups · Device type: Device, Dermal Replacement (MDD)
Published research
The most relevant PubMed records for "Integra"[tiab]. The summary above synthesizes these.
- Use of Integra® on avascular tissue.
Ria S, Chegini S, Ozbek L, et al. · Br J Oral Maxillofac Surg · 2024
- Integra® Dermal Regeneration Template in Complex Scalp Reconstruction.
Turton N, Aggarwal A, Twohig E, et al. · J Clin Med · 2024
- Using Integra for Reconstruction of Facial Defects after Mohs Micrographic Surgery.
Bascone CM, Deitermann A, Lin SK, et al. · Plast Reconstr Surg Glob Open · 2023
- Integra® Dermal Regeneration Template: From Design to Clinical Use.
Taupin P, Gandhi A, Saini S · Cureus · 2023Review
- Integra at Home: A flexible continuum of in-home medical care for older adults with complex needs.
Fulton AT, Vognar L, Stuck AR, et al. · J Am Geriatr Soc · 2024Research Support, Non-U.S. Gov't
- Use of Integra dermal regeneration template in burn patients: An Italian expert consensus Delphi study.
Giudice G, Ranno R, Lombardo G, et al. · Burns · 2024Consensus Statement
- Integra Dermal Regeneration Template in reconstructive surgery for cutaneous tumours: a two-year retrospective review.
Prezzavento GE, Calvi RNJ, Rodriguez JA, et al. · J Wound Care · 2022
- Integra® Dermal Regeneration Template as an alternative technique to treat degloving injury of fingers.
Roels N, Van den Hof B · Acta Chir Belg · 2023
- The Feasibility and Outcome of Integra® Bilayer Matrix in the Reconstruction of Oral Cavity Defects.
Mansour J, Nesbitt B, Khanjae S, et al. · Otolaryngol Head Neck Surg · 2024
- The Basics of Integra Dermal Regeneration Template and its Expanding Clinical Applications.
Chang DK, Louis MR, Gimenez A, et al. · Semin Plast Surg · 2019Review
- One-stage Integra coverage for fingertip injuries.
Jacoby SM, Bachoura A, Chen NC, et al. · Hand (N Y) · 2013
Other devices of this type
Also filed under product code MDD.
- Integra Artificial Skin, Dermal Regeneration TemplateIntegra Lifesciences Corp. · PMA 2012
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.